QC
CVAC

Quent Capital’s CureVac CVAC Stock Holding History

Quent Capital’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,035
Closed -$3.07K – 1360
2024
Q3 		$3.07K Hold
1,035
– – ﹤0.01% 1179
2024
Q2 		$3.51K Hold
1,035
– – ﹤0.01% 1145
2024
Q1 		$3.14K Buy
1,035
+614
+146% +$2.15K ﹤0.01% 1184
2023
Q4 		$1.8K Hold
421
– – ﹤0.01% 1214
2023
Q3 		$2.88K Buy
421
+46
+12% +$406 ﹤0.01% 1143
2023
Q2 		$3.91K Hold
375
– – ﹤0.01% 1090
2023
Q1 		$2.61K Hold
375
– – ﹤0.01% 1139
2022
Q4 		$2.26K Buy
375
+215
+134% +$1.59K ﹤0.01% 1126
2022
Q3 		$1K Buy
+160
New +$1.87K ﹤0.01% 1145

Other funds holding CVAC

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Quent Capital's CVAC Position: Q4 2024 in Review

Quent Capital sold out of CureVac (CVAC) in Q4 2024, closing a stake of 1,035 shares — an estimated $3.07K sold.

Quent Capital first reported a position in CVAC in Q3 2022 and held it in 9 quarters. The position peaked at $3.91K in Q2 2023. 75 funds tracked by Wall St. Rank hold CVAC as of Q4 2024.

  • Quent Capital reported no remaining CureVac position as of Q4 2024 after selling out during the quarter.
  • Quent Capital sold 1,035 CureVac shares in Q4 2024, an estimated $3.07K.
  • Quent Capital first reported a position in CureVac in Q3 2022 and held it in 9 quarters.
  • Quent Capital's CureVac position peaked at $3.91K in Q2 2023.
  • 75 funds tracked by Wall St. Rank held CureVac as of Q4 2024.

Based on Quent Capital's 13F filing for Q4 2024, filed 29 Jan 2025.